{"id":829127,"date":"2025-03-24T16:06:11","date_gmt":"2025-03-24T20:06:11","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/omnicell-welcomes-perry-a-genova-phd-as-chief-technology-officer\/"},"modified":"2025-03-24T16:06:11","modified_gmt":"2025-03-24T20:06:11","slug":"omnicell-welcomes-perry-a-genova-phd-as-chief-technology-officer","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/omnicell-welcomes-perry-a-genova-phd-as-chief-technology-officer\/","title":{"rendered":"Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer<\/b><\/p>\n<p class=\"bwalignc\"><i>Medical device, pharmaceutical, and life sciences expert tapped to lead Company\u2019s technology strategy and global engineering organization<\/i><\/p>\n<p>FORT WORTH, Texas&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nOmnicell, Inc. (Nasdaq: OMCL) (\u201cOmnicell\u201d or the \u201cCompany\u201d), a leader in transforming the pharmacy and nursing care delivery model, today announced that Perry A. Genova, PhD, will join the Company as Senior Vice President, Chief Technology Officer, effective March 31, 2025.\n<\/p>\n<p id=\"news-body-cta\">This press release features multimedia. View the full release here: <a href=\"https:\/\/www.businesswire.com\/news\/home\/20250324514095\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20250324514095\/en\/<\/a><\/p>\n<div id=\"bwbodyimg\" style=\"width: 480px;float:left;padding-left:0px;padding-right:20px;padding-top:0px;padding-bottom:0px\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250324514095\/en\/2418535\/4\/PerryGenova_8024.jpg\" alt=\"Perry A. Genova, PhD, will join the Company as Senior Vice President, Chief Technology Officer, on March 31, 2025. Dr. Genova will lead Omnicell\u2019s technology strategy as the Company works to address pressing issues within medication and supply management across all care settings\" \/><\/p>\n<p style=\"font-size:85%\">Perry A. Genova, PhD, will join the Company as Senior Vice President, Chief Technology Officer, on March 31, 2025. Dr. Genova will lead Omnicell\u2019s technology strategy as the Company works to address pressing issues within medication and supply management across all care settings<\/p>\n<\/div>\n<p>\nIn this role, Dr. Genova will lead Omnicell\u2019s technology strategy as the Company works to address pressing issues within medication and supply management across all care settings in an effort to help customers move closer to the industry-defined vision of the Autonomous Pharmacy.\n<\/p>\n<p>\nDr. Genova brings more than 25 years of experience in product development, strategic planning, and regulatory compliance, with a track-record of success in delivering innovation, growth, and value in senior leadership roles for companies across the medical device, pharmaceutical, and life sciences industries\n<\/p>\n<p>\n\u201cWe believe Perry\u2019s entrepreneurial mindset will be pivotal to advancing our multi-year, outcome-centric growth strategy as we strive to deliver clinical and operational outcomes for our customers,\u201d said Nnamdi Njoku, executive vice president and chief operating officer at Omnicell. \u201cHis focus on building trust and collaboration among strategic partners and internal and external stakeholders will help to drive forward our purpose to transform medication management across all care settings.\u201d\n<\/p>\n<p><b>About Perry Genova<\/b><\/p>\n<p>\nDr. Genova is an industry thought leader with an extensive background focused on delivering innovation, growth, and value as Senior Vice President of Research and Development at EndoQuest Robotics, Inc. and Titan Medical USA, President and CEO at Centauri Robotic Surgical Systems, Inc. and Oncoscope, Inc., and Vice President at GSK plc (formerly GlaxoSmithKline plc) and Kos Pharmaceuticals, Inc. Notable achievements include building an $800M division at Kos Pharmaceuticals, Inc., helping develop a class-leading reservoir insulin device, and holding 58 issued U.S. patents spanning a wide spectrum of medical and consumer technologies. He holds BS, MS, and PhD engineering degrees from the University of North Carolina.\n<\/p>\n<p><b>About Omnicell<\/b><\/p>\n<p>\nSince 1992, Omnicell has been committed to transforming pharmacy and nursing care through outcomes-centric solutions designed to deliver clinical and business outcomes across all settings of care. Through a comprehensive portfolio of robotics and smart devices, intelligent software workflows, and data and analytics, all optimized by expert services, Omnicell solutions are helping healthcare facilities worldwide to uncover cost savings, improve labor efficiency, establish new revenue streams, enhance supply chain control, support compliance, and move closer to the industry-defined vision of the Autonomous Pharmacy. To learn more, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.omnicell.com%2F&amp;esheet=54228138&amp;newsitemid=20250324514095&amp;lan=en-US&amp;anchor=omnicell.com&amp;index=1&amp;md5=e7aa5e241a00649d8d20105b79e59a4c\">omnicell.com<\/a>.\n<\/p>\n<p>\nOMNICELL and the Omnicell logo are registered trademarks of Omnicell, Inc. or one of its subsidiaries.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250324514095r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20250324514095\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20250324514095\/en\/<\/a><\/span><\/p>\n<p>\nBetsy Martinelli<br \/>\n<br \/>Director, Corporate Marketing<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:Betsy.Martinelli@omnicell.com\">Betsy.Martinelli@omnicell.com<br \/>\n<\/a><br \/>412-334-3256\n<\/p>\n<p><b>KEYWORDS:<\/b> United States North America Texas<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Technology Nursing Health Technology Software Delivery Services Pharmaceutical Robotics Health Supply Chain Management Retail<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Photo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250324514095\/en\/2418535\/3\/PerryGenova_8024.jpg\" alt=\"Photo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\">Perry A. Genova, PhD, will join the Company as Senior Vice President, Chief Technology Officer, on March 31, 2025. Dr. Genova will lead Omnicell\u2019s technology strategy as the Company works to address pressing issues within medication and supply management across all care settings<\/font><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250324514095\/en\/770780\/3\/01_omnicell_lockup_horizontal_green_rgb.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer Medical device, pharmaceutical, and life sciences expert tapped to lead Company\u2019s technology strategy and global engineering organization FORT WORTH, Texas&#8211;(BUSINESS WIRE)&#8211; Omnicell, Inc. (Nasdaq: OMCL) (\u201cOmnicell\u201d or the \u201cCompany\u201d), a leader in transforming the pharmacy and nursing care delivery model, today announced that Perry A. Genova, PhD, will join the Company as Senior Vice President, Chief Technology Officer, effective March 31, 2025. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20250324514095\/en\/ Perry A. Genova, PhD, will join the Company as Senior Vice President, Chief Technology Officer, on March 31, 2025. Dr. Genova will lead Omnicell\u2019s technology strategy as the Company works to address pressing issues within medication and &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/omnicell-welcomes-perry-a-genova-phd-as-chief-technology-officer\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-829127","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/omnicell-welcomes-perry-a-genova-phd-as-chief-technology-officer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer Medical device, pharmaceutical, and life sciences expert tapped to lead Company\u2019s technology strategy and global engineering organization FORT WORTH, Texas&#8211;(BUSINESS WIRE)&#8211; Omnicell, Inc. (Nasdaq: OMCL) (\u201cOmnicell\u201d or the \u201cCompany\u201d), a leader in transforming the pharmacy and nursing care delivery model, today announced that Perry A. Genova, PhD, will join the Company as Senior Vice President, Chief Technology Officer, effective March 31, 2025. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20250324514095\/en\/ Perry A. Genova, PhD, will join the Company as Senior Vice President, Chief Technology Officer, on March 31, 2025. Dr. Genova will lead Omnicell\u2019s technology strategy as the Company works to address pressing issues within medication and &hellip; Continue reading &quot;Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/omnicell-welcomes-perry-a-genova-phd-as-chief-technology-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-24T20:06:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250324514095\/en\/2418535\/4\/PerryGenova_8024.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/omnicell-welcomes-perry-a-genova-phd-as-chief-technology-officer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/omnicell-welcomes-perry-a-genova-phd-as-chief-technology-officer\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer\",\"datePublished\":\"2025-03-24T20:06:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/omnicell-welcomes-perry-a-genova-phd-as-chief-technology-officer\\\/\"},\"wordCount\":604,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/omnicell-welcomes-perry-a-genova-phd-as-chief-technology-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250324514095\\\/en\\\/2418535\\\/4\\\/PerryGenova_8024.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/omnicell-welcomes-perry-a-genova-phd-as-chief-technology-officer\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/omnicell-welcomes-perry-a-genova-phd-as-chief-technology-officer\\\/\",\"name\":\"Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/omnicell-welcomes-perry-a-genova-phd-as-chief-technology-officer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/omnicell-welcomes-perry-a-genova-phd-as-chief-technology-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250324514095\\\/en\\\/2418535\\\/4\\\/PerryGenova_8024.jpg\",\"datePublished\":\"2025-03-24T20:06:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/omnicell-welcomes-perry-a-genova-phd-as-chief-technology-officer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/omnicell-welcomes-perry-a-genova-phd-as-chief-technology-officer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/omnicell-welcomes-perry-a-genova-phd-as-chief-technology-officer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250324514095\\\/en\\\/2418535\\\/4\\\/PerryGenova_8024.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250324514095\\\/en\\\/2418535\\\/4\\\/PerryGenova_8024.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/omnicell-welcomes-perry-a-genova-phd-as-chief-technology-officer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/omnicell-welcomes-perry-a-genova-phd-as-chief-technology-officer\/","og_locale":"en_US","og_type":"article","og_title":"Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer - Market Newsdesk","og_description":"Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer Medical device, pharmaceutical, and life sciences expert tapped to lead Company\u2019s technology strategy and global engineering organization FORT WORTH, Texas&#8211;(BUSINESS WIRE)&#8211; Omnicell, Inc. (Nasdaq: OMCL) (\u201cOmnicell\u201d or the \u201cCompany\u201d), a leader in transforming the pharmacy and nursing care delivery model, today announced that Perry A. Genova, PhD, will join the Company as Senior Vice President, Chief Technology Officer, effective March 31, 2025. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20250324514095\/en\/ Perry A. Genova, PhD, will join the Company as Senior Vice President, Chief Technology Officer, on March 31, 2025. Dr. Genova will lead Omnicell\u2019s technology strategy as the Company works to address pressing issues within medication and &hellip; Continue reading \"Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/omnicell-welcomes-perry-a-genova-phd-as-chief-technology-officer\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-24T20:06:11+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250324514095\/en\/2418535\/4\/PerryGenova_8024.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/omnicell-welcomes-perry-a-genova-phd-as-chief-technology-officer\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/omnicell-welcomes-perry-a-genova-phd-as-chief-technology-officer\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer","datePublished":"2025-03-24T20:06:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/omnicell-welcomes-perry-a-genova-phd-as-chief-technology-officer\/"},"wordCount":604,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/omnicell-welcomes-perry-a-genova-phd-as-chief-technology-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250324514095\/en\/2418535\/4\/PerryGenova_8024.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/omnicell-welcomes-perry-a-genova-phd-as-chief-technology-officer\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/omnicell-welcomes-perry-a-genova-phd-as-chief-technology-officer\/","name":"Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/omnicell-welcomes-perry-a-genova-phd-as-chief-technology-officer\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/omnicell-welcomes-perry-a-genova-phd-as-chief-technology-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250324514095\/en\/2418535\/4\/PerryGenova_8024.jpg","datePublished":"2025-03-24T20:06:11+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/omnicell-welcomes-perry-a-genova-phd-as-chief-technology-officer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/omnicell-welcomes-perry-a-genova-phd-as-chief-technology-officer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/omnicell-welcomes-perry-a-genova-phd-as-chief-technology-officer\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250324514095\/en\/2418535\/4\/PerryGenova_8024.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250324514095\/en\/2418535\/4\/PerryGenova_8024.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/omnicell-welcomes-perry-a-genova-phd-as-chief-technology-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/829127","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=829127"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/829127\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=829127"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=829127"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=829127"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}